Mylan (MYL), Actavis (ACT) Continue Lower Following CVS/Cardinal Health Agreement
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Join SI Premium – FREE
Mylan (Nasdaq: MYL), Actavis (NYSE: ACT) are lower Tuesday following CVS (NYSE: CVS) and Cardinal Health (NYSE: CAH) reaching a new generic sourcing entity agreement with Cardinal Health, which is said to be the largest in the U.S.
Mylan is down 3.4 percent, while Actavis is down 2.5 percent.
Mylan is down 3.4 percent, while Actavis is down 2.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
- CVS Health Earns Two Gold and One Silver Stevie(R) Awards for Great Employers
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
